|  |
| |
| Wnt (wingless-type)/β-catenin signaling is a major regulator of cell proliferation, migration and differentiation, controlling tissue homeostasis and tumor progression (Klaus et al., 2008). A) The binding of a canonical Wnt ligand to its cell-surface receptor complex, consisting of Frizzled (FZD) and one of two low-density-lipoprotein- receptor-related proteins (LRP-5 and LRP-6), initiates a signaling cascade that activates disheveled (DVL), which releases β-catenin from an inhibitory complex consisting of Axin, APC and glycogen synthase kinase 3b (GSK3B). On dephosphorylation and release, β-catenin translocates to the nucleus, where it interacts with members of the T-cell factor/lymphoid enhancer factor (TCF/LEF) families of transcription factors to stimulate expression of genes involved in cell survival, proliferation and osteoblastic differentiation (e.g., MMPs, CCND1, PTGS2, MYC, JUN and VEGFR) (Reya et al., 2005). B) Wnt signaling is regulated by several classes of negative regulators. The Secreted Frizzled-Related Protein (SFRP) class comprises SFRP1-SFRP5, Wnt inhibitory factor 1 (WIF1) and Cerberus. SFRPs are a family of soluble glycoproteins that possess a cysteine- rich domain (CRD) structurally similar to the extracellular Wnt-binding domain of the FZD receptors. SFRPs can thus modulate Wnt signaling by sequestering Wnts through their CRD or by acting as dominant-negative inhibitors, forming inactive complexes with the FZD receptors. |
| |
Description | Size: 8487 bases. The SFRP2 gene is located on the long arm of Chromosome 4, and consists of 3 coding exons, with exon 2 being significantly smaller than the other two. No known splice variants. |
Transcription | mRNA size 2005 bp, ORF size 888 bp. |
|  |
| |
Description | SFRP2 contains several domains which potentially govern protein-protein interactions. - Beginning at the N-terminus there is a 24 aa hydrophobic signal domain, which presumably governs the targeting of SFRP2 to the secretory pathway. - The CRD/FZ (cysteine-rich/Frizzled) domain allows SFRP proteins to antagonise Wnt/Frizzled binding at the plasma membrane either by sequestration of the Wnt ligand or dominant-negative binding to complimentary regions within the Frizzled protein. - The C345C/Netrin domain is an accessory binding domain for SFRP2-Wnt interaction. - The PDZ ligand domain is a short sequence which is recognised by PDZ proteins such as Dishevelled (Dvl), and other proteins which interact with the cytoplasmic portion of Frizzled (Schulte and Bryja, 2007). Notably, a recent study (Zhang et al., 2009) has used synthetic PDZ ligands to interfere with Dvl/FZD cytoplasmic interaction, and thus antagonise canonical Wnt signalling. Additionally, another group subsequently showed that the NSAID Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of Dvl (Lee et al., 2009). These data suggest that the presence of a PDZ ligand in SFRP2 may indicate a previously-unexplored role for SFRP2 as a cytoplasmic antagonist of Wnt signalling. - A phosphoproteomic study has revealed phosphorylation of SFRP2 at serine-289 in response to growth factor stimulation (Olsen et al., 2006). Bioinformatic analysis suggests that this site is a motif for recognition and phosphorylation by PKA. Additionally, bioinformatic analysis of the SFRP2 sequence suggests a site for phosphorylation by GSK3β (itself an inhibitor of β-catenin) at either serine-34 or serine-38. Although the potential significance of phosphorylation at this site is unclear, it may overlap with the Nec 1/Nec 2 cleavage site and prevent removal of the N-terminal signal domain. Typically, Nec 1/2 is responsible for the cleavage of pro-proteins into their active form, and perhaps phosphorylation in this region is a mechanism by which GSK3β may regulate SFRP2 activity. |
Expression | Widely expressed. |
Localisation | Nucleus, cytoplasm and secreted. |
Function | SFRP2 is a member of the secreted Frizzled-related protein (SFRP) family of soluble extracellular Wnt antagonists, which act in conjunction with the Dickkopf (DKK) class of Wnt antagonists. SFRP2 is thought to act primarily by binding directly to and sequestering Wnt ligands, but may also act by direct binding to the Wnt-receptor complex. Binding occurs primarily via the cysteine-rich domain, which bears a high degree of homology to similar domains in the Frizzled (Fzd) receptor. SFRP activity may conversely promote Wnt pathway signalling in some contexts, as a consequence of SFRP proteins interacting with each other and titrating each others' activity, or by SFRP binding and stabilising Wnt-Fzd complexes. |
Homology | SFRP2 has a high degree of homology to both other SFRP family members, as well as Fzd receptors via the cysteine-rich domain. |
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. |
Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J. |
J Cell Sci. 2008 Mar 15;121(Pt 6):737-46. doi: 10.1242/jcs.026096. (REVIEW) |
PMID 18322270 |
|
Secreted Frizzled-related proteins: searching for relationships and patterns. |
Jones SE, Jomary C. |
Bioessays. 2002 Sep;24(9):811-20. (REVIEW) |
PMID 12210517 |
|
Wnt signalling and its impact on development and cancer. |
Klaus A, Birchmeier W. |
Nat Rev Cancer. 2008 May;8(5):387-98. doi: 10.1038/nrc2389. |
PMID 18432252 |
|
Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin. |
Lavergne E, Hendaoui I, Coulouarn C, Ribault C, Leseur J, Eliat PA, Mebarki S, Corlu A, Clement B, Musso O. |
Oncogene. 2011 Jan 27;30(4):423-33. doi: 10.1038/onc.2010.432. Epub 2010 Sep 20. |
PMID 20856206 |
|
Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein Dishevelled. |
Lee HJ, Wang NX, Shi DL, Zheng JJ. |
Angew Chem Int Ed Engl. 2009;48(35):6448-52. doi: 10.1002/anie.200902981. |
PMID 19637179 |
|
The role of secreted frizzled-related protein 2 expression in prostate cancer. |
O'Hurley G, Perry AS, O'Grady A, Loftus B, Smyth P, O'Leary JJ, Sheils O, Fitzpatrick JM, Hewitt SM, Lawler M, Kay EW. |
Histopathology. 2011 Dec;59(6):1240-8. doi: 10.1111/j.1365-2559.2011.04073.x. |
PMID 22175903 |
|
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. |
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. |
Cell. 2006 Nov 3;127(3):635-48. |
PMID 17081983 |
|
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer. |
Perry AS, O'Hurley G, Raheem OA, Brennan K, Wong S, O'Grady A, Kennedy AM, Marignol L, Murphy TM, Sullivan L, Barrett C, Loftus B, Thornhill J, Hewitt SM, Lawler M, Kay E, Lynch T, Hollywood D. |
Int J Cancer. 2013 Apr 15;132(8):1771-80. doi: 10.1002/ijc.27798. Epub 2012 Sep 28. |
PMID 22915211 |
|
Wnt signalling in stem cells and cancer. |
Reya T, Clevers H. |
Nature. 2005 Apr 14;434(7035):843-50. (REVIEW) |
PMID 15829953 |
|
The Frizzled family of unconventional G-protein-coupled receptors. |
Schulte G, Bryja V. |
Trends Pharmacol Sci. 2007 Oct;28(10):518-25. Epub 2007 Sep 19. (REVIEW) |
PMID 17884187 |
|
Inhibition of Wnt signaling by Dishevelled PDZ peptides. |
Zhang Y, Appleton BA, Wiesmann C, Lau T, Costa M, Hannoush RN, Sidhu SS. |
Nat Chem Biol. 2009 Apr;5(4):217-9. doi: 10.1038/nchembio.152. Epub 2009 Mar 1. |
PMID 19252499 |
|